Lonza Group AG (OTCMKTS:LZAGY) Short Interest Up 64.6% in April

Lonza Group AG (OTCMKTS:LZAGY) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 7,900 shares, a growth of 64.6% from the March 31st total of 4,800 shares. Based on an average daily trading volume, of 186,200 shares, the days-to-cover ratio is presently 0.0 days.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft upgraded Lonza Group from a “hold” rating to a “buy” rating in a report on Friday, February 2nd.

Lonza Group Stock Performance

OTCMKTS LZAGY traded down $0.52 on Monday, reaching $57.27. The stock had a trading volume of 38,611 shares, compared to its average volume of 156,042. The business has a 50 day moving average price of $56.02 and a 200 day moving average price of $46.67. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.20 and a current ratio of 1.77. Lonza Group has a 1 year low of $34.19 and a 1 year high of $66.00.

Lonza Group Company Profile

Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments. The Biologics segment engages in the contract development and manufacturing of biopharmaceuticals for clinical and commercial manufacturing needs throughout the product lifecycle, including drug substance and drug product manufacturing.